|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 408.00 USD | +6.04% |
|
-.--% | -6.49% |
| 05-11 | Virbac continues decline despite positive recommendation |  |
| 04-17 | Virbac: 2026 starts on strong footing |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VIRBAC | Veterinary Drugs | +6.04% | -.--% | -6.49% | +17.92% | +25.93% | 3.31B |
-
|
-
|
-
|
- Stock Market
- Stocks
- VIRP Stock
- VRBC.F Stock
- Charts Virbac
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
